Updated on 2024/02/01

写真a

 
Naomi Kamimura
 
Affiliation
Faculty of Medicine, Laboratory for Clinical Research, Collaborative Research Center, Associate Professor
Title
Associate Professor
External link

Degree

  • 博士(医学) ( 東京大学 )

Research Interests

  • ミトコンドリア

  • 炎症

  • 糖尿病

  • 酸化ストレス

Research Areas

  • Life Science / Cell biology

Research History

  • Nippon Medical School   Associate Professor

    2020.9

      More details

  • Nippon Medical School   Associate Professor

    2013.4 - 2020.8

      More details

  • Nippon Medical School   Institute for Advanced Medical Sciences   Senior Assistant Professor

    2009.4 - 2013.3

      More details

  • Nippon Medical School   Assistant Professor

    2007.4 - 2009.3

      More details

  • Nippon Medical School

    2003.4 - 2007.3

      More details

  • Nippon Medical School

    2001.4 - 2003.3

      More details

  • National Institute of Genetics

    1999.6 - 2001.3

      More details

  • Osaka University   Research Institute for Microbial Diseases

    1996.6 - 1999.5

      More details

  • 日本学術振興会   特別研究員

    1996.4 - 1996.5

      More details

▼display all

Professional Memberships

  • THE JAPANESE SOCIETY OF MITOCHONDRIAL RESEARCH AND MEDICINE

      More details

  • THE JAPANESE PHARMACOLOGICAL SOCIETY

      More details

  • THE MOLECULAR BIOLOGY SOCIETY OF JAPAN

      More details

Papers

  • Transgenic type2 diabetes mouse models for in vivo redox measurement of hepatic mitochondrial oxidative stress. International journal

    Naomi Kamimura, Alexander M Wolf, Takashi Yokota, Chikako Nito, Hiroshi Takahashi, Shigeo Ohta

    Biochimica et biophysica acta. General subjects   1867 ( 3 )   130302 - 130302   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Oxidative stress is involved in the progression of diabetes and its associated complications. However, it is unclear whether increased oxidative stress plays a primary role in the onset of diabetes or is a secondary indicator caused by tissue damage. Previous methods of analyzing oxidative stress have involved measuring the changes in oxidative stress biomarkers. Our aim is to identify a novel approach to clarify whether oxidative stress plays a primary role in the onset of diabetes. METHODS: We constructed transgenic type 2 diabetes mouse models expressing redox-sensitive green fluorescent proteins (roGFPs) that distinguished between mitochondria and whole cells. Pancreas, liver, skeletal muscle, and kidney redox states were measured in vivo. RESULTS: Hepatic mitochondrial oxidation increased when the mice were 4 weeks old and continued to increase in an age-dependent manner. The increase in hepatic mitochondrial oxidation occurred simultaneously with weight gain and increased blood insulin levels before the blood glucose levels increased. Administering the oxidative stress inducer acetaminophen increased the vulnerability of the liver mitochondria to oxidative stress. CONCLUSIONS: This study demonstrates that oxidative stress in liver mitochondria in mice begins at the onset of diabetes rather than after the disease has progressed. GENERAL SIGNIFICANCE: RoGFP-expressing transgenic type 2 diabetes mouse models are effective and convenient tools for measuring hepatic mitochondrial redox statuses in vivo. These models may be used to assess mitochondria-targeting antioxidants and establish the role of oxidative stress in type 2 diabetes.

    DOI: 10.1016/j.bbagen.2022.130302

    PubMed

    researchmap

  • Molecular hydrogen suppresses free-radical-induced cell death by mitigating fatty acid peroxidation and mitochondrial dysfunction. Reviewed International journal

    Katsuya Iuchi, Kiyomi Nishimaki, Naomi Kamimura, Shigeo Ohta

    Canadian journal of physiology and pharmacology   97 ( 10 )   999 - 1005   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Molecular hydrogen (H2) was believed to be an inert and nonfunctional molecule in mammalian cells; however, we overturned the concept by reporting the therapeutic effects of H2 against oxidative stress. Subsequently, extensive studies revealed multiple functions of H2 by exhibiting the efficacies of H2 in various animal models and clinical studies. Here, we investigated the effect of H2 on free-radical-induced cytotoxicity using tert-butyl hydroperoxide in a human acute monocytic leukemia cell line, THP-1. Cell membrane permeability was determined using lactate dehydrogenase release assay and Hoechst 33342 and propidium iodide staining. Fatty acid peroxidation and mitochondrial viability were measured using 2 kinds of fluorescent dyes, Liperfluo and C11-BODIPY, and using the alamarBlue assay based on the reduction of resazurin to resorufin by mainly mitochondrial succinate dehydrogenase, respectively. Mitochondrial membrane potential was evaluated using tetramethylrhodamine methyl ester. As a result, H2 protected the cultured cells against the cytotoxic effects induced by tert-butyl hydroperoxide; H2 suppressed cellular fatty acid peroxidation and cell membrane permeability, mitigated the decline in mitochondrial oxidoreductase activity and mitochondrial membrane potential, and protected cells against cell death evaluated using propidium iodide staining. These results suggested that H2 suppresses free-radical-induced cell death through protection against fatty acid peroxidation and mitochondrial dysfunction.

    DOI: 10.1139/cjpp-2018-0741

    PubMed

    researchmap

  • Rap1b Promotes Notch-Signal-Mediated Hematopoietic Stem Cell Development by Enhancing Integrin-Mediated Cell Adhesion. Reviewed International journal

    Seung-Sik Rho, Isao Kobayashi, Eri Oguri-Nakamura, Koji Ando, Masakazu Fujiwara, Naomi Kamimura, Hiromi Hirata, Atsuo Iida, Yoshiko Iwai, Naoki Mochizuki, Shigetomo Fukuhara

    Developmental cell   49 ( 5 )   681 - 696   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Hematopoietic stem cells (HSCs) emerge from hemogenic endothelium (HE) within the ventral portion of the dorsal aorta during vertebrate development. In zebrafish, Notch signaling induces HE specification from posterior lateral plate mesoderm (PLPM) cells as they migrate over the ventral surface of the somite. During migration, PLPM cells make close contact with Notch-ligand-expressing somitic cells to acquire HE identity. Herein, we show in zebrafish that the small GTPase Rap1b regulates HSC development by potentiating Notch-mediated HE specification. PLPM cells migrate toward the midline along the somite boundary where fibronectin accumulates. Rap1b stimulates integrin β1 to enhance PLPM cell adhesion to fibronectin localized at the somite boundary. Rap1b-induced integrin-β1-mediated adhesion to fibronectin leads to the spreading of PLPM cells to facilitate their physical contact with the Notch-ligand-expressing somitic cells, thereby promoting Notch-mediated HE specification. Thus, we have revealed an unexpected role of Rap1-induced integrin-mediated cell adhesion in HSC development.

    DOI: 10.1016/j.devcel.2019.03.023

    PubMed

    researchmap

  • Development of Cancer Immunotherapy Targeting the PD-1 Pathway. Reviewed

    Kamimura N, Wolf AM, Iwai Y

    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi   86 ( 1 )   10 - 14   2019

  • Taurine supplementation for prevention of stroke-like episodes in MELAS: A multicentre, open-label, 52-week phase III trial Reviewed

    Yutaka Ohsawa, Hiroki Hagiwara, Shin-Ichiro Nishimatsu, Akihiro Hirakawa, Naomi Kamimura, Hideaki Ohtsubo, Yuta Fukai, Tatsufumi Murakami, Yasutoshi Koga, Yu-Ichi Goto, Shigeo Ohta, Yoshihide Sunada

    Journal of Neurology, Neurosurgery and Psychiatry   90 ( 5 )   529 - 536   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMJ Publishing Group  

    Objective: The aim of this study was to evaluate the efficacy and safety of high-dose taurine supplementation for prevention of stroke-like episodes of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), a rare genetic disorder caused by point mutations in the mitochondrial DNA that lead to a taurine modification defect at the first anticodon nucleotide of mitochondrial tRNALeu(UUR), resulting in failure to decode codons accurately. Methods: After the nationwide survey of MELAS, we conducted a multicentre, open-label, phase III trial in which 10 patients with recurrent stroke-like episodes received high-dose taurine (9 g or 12 g per day) for 52 weeks. The primary endpoint was the complete prevention of stroke-like episodes during the evaluation period. The taurine modification rate of mitochondrial tRNALeu(UUR) was measured before and after the trial. Results: The proportion of patients who reached the primary endpoint (100% responder rate) was 60% (95% CI 26.2% to 87.8%). The 50% responder rate, that is, the number of patients achieving a 50% or greater reduction in frequency of stroke-like episodes, was 80% (95% CI 44.4% to 97.5%). Taurine reduced the annual relapse rate of stroke-like episodes from 2.22 to 0.72 (P=0.001). Five patients showed a significant increase in the taurine modification of mitochondrial tRNALeu(UUR) from peripheral blood leukocytes (P&lt
    0.05). No severe adverse events were associated with taurine. Conclusions: The current study demonstrates that oral taurine supplementation can effectively reduce the recurrence of stroke-like episodes and increase taurine modification in mitochondrial tRNALeu(UUR) in MELAS. Trial registration number: UMIN000011908.

    DOI: 10.1136/jnnp-2018-317964

    Scopus

    PubMed

    researchmap

  • Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment. Reviewed International journal

    Nishimaki K, Asada T, Ohsawa I, Nakajima E, Ikejima C, Yokota T, Kamimura N, Ohta S

    Current Alzheimer research   15 ( 5 )   482 - 492   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Oxidative stress is one of the causative factors in the pathogenesis of neurodegenerative diseases including mild cognitive impairment (MCI) and dementia. We previously reported that molecular hydrogen (H2) acts as a therapeutic and preventive antioxidant. OBJECTIVE: We assess the effects of drinking H2-water (water infused with H2) on oxidative stress model mice and subjects with MCI. METHODS: Transgenic mice expressing a dominant-negative form of aldehyde dehydrogenase 2 were used as a dementia model. The mice with enhanced oxidative stress were allowed to drink H2-water. For a randomized double-blind placebo-controlled clinical study, 73 subjects with MCI drank ~300 mL of H2-water (H2-group) or placebo water (control group) per day, and the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) scores were determined after 1 year. RESULTS: In mice, drinking H2-water decreased oxidative stress markers and suppressed the decline of memory impairment and neurodegeneration. Moreover, the mean lifespan in the H2-water group was longer than that of the control group. In MCI subjects, although there was no significant difference between the H2- and control groups in ADAS-cog score after 1 year, carriers of the apolipoprotein E4 (APOE4) genotype in the H2-group were improved significantly on total ADAS-cog score and word recall task score (one of the sub-scores in the ADAS-cog score). CONCLUSION: H2-water may have a potential for suppressing dementia in an oxidative stress model and in the APOE4 carriers with MCI.

    DOI: 10.2174/1567205014666171106145017

    PubMed

    researchmap

  • Protective Effect of Hydrogen Gas Inhalation on Muscular Damage Using a Mouse Hindlimb Ischemia-Reperfusion Injury Model. Reviewed International journal

    Mai Watanabe, Naomi Kamimura, Katsuya Iuchi, Kiyomi Nishimaki, Takashi Yokota, Rei Ogawa, Shigeo Ohta

    Plastic and reconstructive surgery   140 ( 6 )   1195 - 1206   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Ischemia-reperfusion injury is one of the leading causes of tissue damage and dysfunction, in particular, free tissue transfer, traumatically amputated extremity, and prolonged tourniquet application during extremity surgery. In this study, the authors investigated the therapeutic effects of hydrogen gas on skeletal muscle ischemia-reperfusion injury. METHODS: The authors compared the concentration of hydrogen in a muscle on intraperitoneal administration of hydrogen-rich saline and on inhalation of hydrogen gas. Animals were subjected to ischemia-reperfusion. Mice were treated with inhalation of hydrogen gas, and the hind gastrocnemius muscle was collected. Muscle morphology and inflammatory change were evaluated after ischemia-reperfusion. Moreover, a footprint test was performed to assess the functional effect of hydrogen. RESULTS: Hydrogen concentration of tissue was significantly higher, and the elevated level was maintained longer by hydrogen gas inhalation than by intraperitoneal administration of hydrogen-rich saline. Infarct zone and area with loss of tissue structure and marked cellular infiltration were significantly decreased in groups treated by hydrogen gas inhalation during ischemia-reperfusion; however, these effects were not observed by posttreatment of hydrogen. One week after ischemia-reperfusion, mice that had been pretreated with hydrogen gas recovered faster and achieved smoother walking in appearance compared with mice in the other groups as assessed by the footprint test. CONCLUSIONS: Inhalation of hydrogen gas attenuates muscle damage, inhibits inflammatory response, and enhances functional recovery. These findings suggest that the optimal route for hydrogen delivery is continuous inhalation of hydrogen gas, which could be a novel clinical mode of treatment in ischemia-reperfusion injury.

    DOI: 10.1097/PRS.0000000000003878

    PubMed

    researchmap

  • Cisplatin selects short forms of the mitochondrial DNA OriB variant (16184-16193 poly-cytosine tract), which confer resistance to cisplatin Reviewed

    Taku Amo, Naomi Kamimura, Hiromasa Asano, Sadamitsu Asoh, Shigeo Ohta

    SCIENTIFIC REPORTS   7   46240   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    A number of alternations in mitochondrial DNA (mtDNA) have been reported in different types of cancers, and the role of mtDNA in cancer has been attracting increasing interest. In order to investigate the relationship between mtDNA alternations and chemosensitivity, we constructed cybrid (trans-mitochondrial hybrid) cell lines carrying a HeLa nucleus and the mtDNA of healthy individuals because of the presence of somatic alternations in the mtDNA of many cancer cells. After a treatment with 1.0 mu g/mL cisplatin for 10 days, we isolated 100 cisplatin-resistant clones, 70 of which carried the shorter mtDNA OriB variant (16184-16193 poly-cytosine tract), which was located in the control region of mtDNA. Whole mtDNA sequencing of 10 clones revealed no additional alternations. Re-construction of the HeLa nucleus and mtDNA from cisplatin-resistant cells showed that cisplatin resistance was only acquired by mtDNA alternations in the control region, and not by possible alternation(s) in the nuclear genome.

    DOI: 10.1038/srep46240

    Web of Science

    PubMed

    researchmap

  • The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure Reviewed

    Tomohiko Ono, Naomi Kamimura, Tomohiro Matsuhashi, Toshihiro Nagai, Takahiko Nishiyama, Jin Endo, Takako Hishiki, Tsuyoshi Nakanishi, Noriaki Shimizu, Hirotoshi Tanaka, Shigeo Ohta, Makoto Suematsu, Masaki Ieda, Motoaki Sano, Keiichi Fukuda, Ruri Kaneda

    SCIENTIFIC REPORTS   7   39752   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Histone acetylation has been linked to cardiac hypertrophy and heart failure. However, the pathological implications of changes in histone methylation and the effects of interventions with histone methyltransferase inhibitors for heart failure have not been fully clarified. Here, we focused on H3K9me3 status in the heart and investigated the effects of the histone H3K9 methyltransferase inhibitor chaetocin on prognoses in Dahl salt-sensitive rats, an animal model of chronic heart failure. Chaetocin prolonged survival and restored mitochondrial dysfunction. ChIP-seq analysis demonstrated that chronic stress to the heart induced H3K9me3 elevation in thousands of repetitive elements, including intronic regions of mitochondria-related genes, such as the gene encoding peroxisome proliferator-activated receptor-gamma coactivator 1 alpha. Furthermore, chaetocin reversed this effect on these repetitive loci. These data suggested that excessive heterochromatinization of repetitive elements of mitochondrial genes in the failing heart may lead to the silencing of genes and impair heart function. Thus, chaetocin may be a potential therapeutic agent for chronic heart failure.

    DOI: 10.1038/srep39752

    Web of Science

    PubMed

    researchmap

  • Symposium13-4

    Japanese Journal of Physical Fitness and Sports Medicine   66 ( 1 )   63 - 63   2017

     More details

    Language:Japanese   Publisher:The Japanese Society of Physical Fitness and Sports Medicine  

    DOI: 10.7600/jspfsm.66.63_2

    researchmap

  • Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(Shl) mice deficient in apolipoprotein E expression Reviewed

    Takashi Yokota, Koichi Nomura, Mikio Nagashima, Naomi Kamimura

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY   32   46 - 54   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Fucoidan, a sulfated polysaccharide extracted from brown seaweeds, possesses many biological activities including anti-inflammatory and antioxidantactivities. We aimed to investigate the protective effects of fucoidan on dyslipidemia and atherosclerosis in apolipoprotein E-deficient mice (ApoE(shl) mice) and to elucidate its molecular targets in the liver by using a transcriptomic approach. For 12 weeks, ApoE(shl) mice were fed a high-fat diet (HFD) supplemented with either 1% or 5% fucoidan. Fucoidan supplementation significantly reduced tissue weight (liver and white adipose tissue), blood lipid, total cholesterol (TC), triglyceride (TG), non-high-density lipoprotein cholesterol (non-HDL-C) and glucose levels in HFD-fed ApoE(shl) mice but increased plasma lipoprotein lipase (LPL) activity and HDL-C levels. Fucoidan also reduced hepatic steatosis levels (liver size, TC and TG levels, and lipid peroxidation) and increased white adipose tissue LPL activity. DNA microarray analysis and quantitative reverse transcription-polymerase chain reaction demonstrated differential expression of genes encoding proteins involved in lipid metabolism, energy homeostasis and insulin sensitivity, by activating Ppara and inactivating Srebf1. Fucoidan supplementation markedly reduced the thickness of the lipid-rich plaque, lipid peroxidation and foaming macrophage accumulation in the aorta in HFD-fed ApoE(shl) mice. Thus, fucoidan supplementation appears to have anti-dyslipidemic and anti-atherosclerotic effects by inducing LPL activity and inhibiting the effects of inflammation and oxidative stress in HFD-fed ApoE(shl) mice. (C) 2016 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jnutbio.2016.01.011

    Web of Science

    PubMed

    researchmap

  • Molecular hydrogen regulates gene expression by modifying the free radical chain reaction-dependent generation of oxidized phospholipid mediators. Reviewed International journal

    Katsuya Iuchi, Akemi Imoto, Naomi Kamimura, Kiyomi Nishimaki, Harumi Ichimiya, Takashi Yokota, Shigeo Ohta

    Scientific reports   6   18971 - 18971   2016.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We previously showed that H2 acts as a novel antioxidant to protect cells against oxidative stress. Subsequently, numerous studies have indicated the potential applications of H2 in therapeutic and preventive medicine. Moreover, H2 regulates various signal transduction pathways and the expression of many genes. However, the primary targets of H2 in the signal transduction pathways are unknown. Here, we attempted to determine how H2 regulates gene expression. In a pure chemical system, H2 gas (approximately 1%, v/v) suppressed the autoxidation of linoleic acid that proceeds by a free radical chain reaction, and pure 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine (PAPC), one of the major phospholipids, was autoxidized in the presence or absence of H2. H2 modified the chemical production of the autoxidized phospholipid species in the cell-free system. Exposure of cultured cells to the H2-dependently autoxidized phospholipid species reduced Ca(2+) signal transduction and mediated the expression of various genes as revealed by comprehensive microarray analysis. In the cultured cells, H2 suppressed free radical chain reaction-dependent peroxidation and recovered the increased cellular Ca(2+), resulting in the regulation of Ca(2+)-dependent gene expression. Thus, H2 might regulate gene expression via the Ca(2+) signal transduction pathway by modifying the free radical-dependent generation of oxidized phospholipid mediators.

    DOI: 10.1038/srep18971

    PubMed

    researchmap

  • Molecular hydrogen stimulates the gene expression of transcriptional coactivator PGC-1α to enhance fatty acid metabolism. Reviewed International journal

    Naomi Kamimura, Harumi Ichimiya, Katsuya Iuchi, Shigeo Ohta

    NPJ aging and mechanisms of disease   2   16008 - 16008   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We previously reported that molecular hydrogen (H2) acts as a novel antioxidant to exhibit multiple functions. Moreover, long-term drinking of H2-water (water infused with H2) enhanced energy expenditure to improve obesity and diabetes in db/db mice accompanied by the increased expression of fibroblast growth factor 21 (FGF21) by an unknown mechanism. H2 was ingested by drinking of H2-water or by oral administration of an H2-producing material, MgH2. The comprehensive gene expression profile in the liver of db/db mice was analyzed by DNA microarray. The molecular mechanisms underlying the gene expression profile was investigated using cultured HepG2 cells. Moreover, the effects on lifespan of drinking H2-water were examined using wild-type mice that were fed a fatty diet. Pathway analyses based on comprehensive gene expression revealed the increased expression of various genes involved in fatty acid and steroid metabolism. As a transcription pathway, the PPARα signaling pathway was identified to upregulate their genes by ingesting H2. As an early event, the gene expression of PGC-1α was transiently increased, followed by increased expression of FGF21. The expression of PGC-1α might be regulated indirectly through sequential regulation by H2, 4-hydroxy-2-nonenal, and Akt/FoxO1 signaling, as suggested in cultured cell experiments. In wild-type mice fed the fatty diet, H2-water improved the level of plasma triglycerides and extended their average of lifespan. H2 induces expression of the PGC-1α gene, followed by stimulation of the PPARα pathway that regulates FGF21, and the fatty acid and steroid metabolism.

    DOI: 10.1038/npjamd.2016.8

    PubMed

    researchmap

  • Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina Reviewed

    Takashi Yokota, Naomi Kamimura, Tsutomu Igarashi, Hiroshi Takahashi, Shigeo Ohta, Hideaki Oharazawa

    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY   43 ( 6 )   568 - 577   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    BackgroundOxidative and nitrative processes have an important role in the pathogenesis of glaucomatous neurodegeneration. Oxidative stress occurs when cellular production of reactive oxygen species outweighs the protective capacity of antioxidant defences. Reactive oxygen species are generated as by-products of cellular metabolism, primarily in the mitochondria. Herein, we present a novel investigation of the effects of molecular hydrogen (H-2) on retinal cells exposed to oxidative stress.
    MethodsWe cultured adult rat retinal tissues in an organotypic culture system with a nitric oxide donor, S-nitroso-N-acetylpenicillamine, in the presence or absence of H-2. Loss of mitochondrial membrane potential and apoptosis of retinal cells were analysed using a MitoTMRE detection kit and TdT-mediated dUTP nick end labeling (TUNEL) assay, respectively. Tyrosine nitration levels and oxidative stress damage in the retina were evaluated using immunohistochemical staining. Retinal damage was quantified by measuring the numbers of cells in the ganglion cell and inner nuclear layers and the thickness of the retina.
    ResultsH(2) suppressed loss of mitochondrial membrane potential and apoptosis in retinal cells. Moreover, H-2 decreased the tyrosine nitration level and suppressed oxidative stress damage in retinal cells. S-nitroso-N-acetylpenicillamine treatment decreased the cell numbers in the ganglion cell layer and inner nuclear layer, but the presence of H-2 inhibited this reduction. These findings suggest that H-2 has a neuroprotective effect against retinal cell oxidative damage, presumably by scavenging peroxynitrite.
    ConclusionsH(2) reduces cellular peroxynitrite, a highly toxic reactive nitrogen species. Thus, H-2 may be an effective and novel clinical tool for treating glaucoma and other oxidative stress-related diseases.

    DOI: 10.1111/ceo.12525

    Web of Science

    PubMed

    researchmap

  • Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease. Reviewed International journal

    Takuya Kanamaru, Naomi Kamimura, Takashi Yokota, Kiyomi Nishimaki, Katsuya Iuchi, Hyunjin Lee, Shinya Takami, Hiroki Akashiba, Yoshitsugu Shitaka, Masayuki Ueda, Ken-Ichiro Katsura, Kazumi Kimura, Shigeo Ohta

    Brain research   1605   49 - 58   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Stem cell transplantation therapy is currently in clinical trials for the treatment of ischemic stroke, and several beneficial aspects have been reported. Similarly, in Alzheimer's disease (AD), stem cell therapy is expected to provide an efficient therapeutic approach. Indeed, the intracerebral transplantation of stem cells reduced amyloid-β (Aβ) deposition and rescued memory deficits in AD model mice. Here, we show that intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) improves cognitive function in two different AD mouse models, DAL and APP mice, and prevents neurodegeneration. GFP-positive BMMCs were isolated from tibiae and femurs of 4-week-old mice and then transplanted intravenously into DAL and APP mice. Transplantation of BMMCs suppressed neuronal loss and restored memory impairment of DAL mice to almost the same level as in wild-type mice. Transplantation of BMMCs to APP mice reduced Aβ deposition in the brain. APP mice treated with BMMCs performed significantly better on behavioral tests than vehicle-injected mice. Moreover, the effects were observed even with transplantation after the onset of cognitive impairment in DAL mice. Together, our results indicate that intravenous transplantation of BMMCs has preventive effects against the cognitive decline in AD model mice and suggest a potential therapeutic effect of BMMC transplantation therapy.

    DOI: 10.1016/j.brainres.2015.02.011

    PubMed

    researchmap

  • Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease. Reviewed International journal

    Takuya Kanamaru, Naomi Kamimura, Takashi Yokota, Katsuya Iuchi, Kiyomi Nishimaki, Shinya Takami, Hiroki Akashiba, Yoshitsugu Shitaka, Ken-Ichiro Katsura, Kazumi Kimura, Shigeo Ohta

    Neuroscience letters   587   126 - 31   2015.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Oxidative stress is known to play a prominent role in the onset and early stage progression of Alzheimer's disease (AD). For example, protein oxidation and lipid peroxidation levels are increased in patients with mild cognitive impairment. Here, we created a double-transgenic mouse model of AD to explore the pathological and behavioral effects of oxidative stress. Double transgenic (APP/DAL) mice were constructed by crossing Tg2576 (APP) mice, which express a mutant form of human amyloid precursor protein (APP), with DAL mice expressing a dominant-negative mutant of mitochondrial aldehyde dehydrogenase 2 (ALDH2), in which oxidative stress is enhanced. Y-maze and object recognition tests were performed at 3 and 6 months of age to evaluate learning and memory. The accumulation of amyloid plaques, deposition of phosphorylated-tau protein, and number of astrocytes in the brain were assessed histopathologically at 3, 6, 9, and 12-15 months of age. The life span of APP/DAL mice was significantly shorter than that of APP or DAL mice. In addition, they showed accelerated amyloid deposition, tau phosphorylation, and gliosis. Furthermore, these mice showed impaired performance on Y-maze and object recognition tests at 3 months of age. These data suggest that oxidative stress accelerates cognitive dysfunction and pathological insults in the brain. APP/DAL mice could be a useful model for exploring new approaches to AD treatment.

    DOI: 10.1016/j.neulet.2014.12.033

    PubMed

    researchmap

  • Hydrogen Inhalation During Normoxic Resuscitation Improves Neurological Outcome in a Rat Model of Cardiac Arrest Independently of Targeted Temperature Management Reviewed

    Kei Hayashida, Motoaki Sano, Naomi Kamimura, Takashi Yokota, Masaru Suzuki, Shigeo Ohta, Keiichi Fukuda, Shingo Hori

    CIRCULATION   130 ( 24 )   2173 - 2180   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Background-We have previously shown that hydrogen (H-2) inhalation, begun at the start of hyperoxic cardiopulmonary resuscitation, significantly improves brain and cardiac function in a rat model of cardiac arrest. Here, we examine the effectiveness of this therapeutic approach when H-2 inhalation is begun on the return of spontaneous circulation (ROSC) under normoxic conditions, either alone or in combination with targeted temperature management (TTM).
    Methods and Results-Rats were subjected to 6 minutes of ventricular fibrillation cardiac arrest followed by cardiopulmonary resuscitation. Five minutes after achieving ROSC, post-cardiac arrest rats were randomized into 4 groups: mechanically ventilated with 26% O-2 and normothermia (control); mechanically ventilated with 26% O-2, 1.3% H-2, and normothermia (H-2); mechanically ventilated with 26% O-2 and TTM (TTM); and mechanically ventilated with 26% O-2, 1.3% H-2, and TTM (TTM+H-2). Animal survival rate at 7 days after ROSC was 38.4% in the control group, 71.4% in the H-2 and TTM groups, and 85.7% in the TTM+H-2 group. Combined therapy of TTM and H-2 inhalation was superior to TTM alone in terms of neurological deficit scores at 24, 48, and 72 hours after ROSC, and motor activity at 7 days after ROSC. Neuronal degeneration and microglial activation in a vulnerable brain region was suppressed by both TTM alone and H-2 inhalation alone, with the combined therapy of TTM and H-2 inhalation being most effective.
    Conclusions-H-2 inhalation was beneficial when begun after ROSC, even when delivered in the absence of hyperoxia. Combined TTM and H-2 inhalation was more effective than TTM alone.

    DOI: 10.1161/CIRCULATIONAHA.114.011848

    Web of Science

    PubMed

    researchmap

  • Real-Time Monitoring of Oxidative Stress in Live Mouse Skin Reviewed

    Alexander M. Wolf, Kiyomi Nishimaki, Naomi Kamimura, Shigeo Ohta

    JOURNAL OF INVESTIGATIVE DERMATOLOGY   134 ( 6 )   1701 - 1709   2014.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Oxidative stress is involved in many age-associated diseases, as well as in the aging process itself. The development of interventions to reduce oxidative stress is hampered by the absence of sensitive detection methods that can be used in live animals. We generated transgenic mice expressing ratiometric redox-sensitive green fluorescent protein (roGFP) in the cytosol or mitochondria of several tissues, including skin epidermal keratinocytes. Crossbreeding into hairless albino mice allowed noninvasive optical measurement of skin oxidative state. Topical application of hydrogen peroxide emulsion shifted the keratinocyte redox state toward oxidation within minutes and could be observed in real time by fluorescence ratio imaging. Exposing skin to 365 nm UVA radiation oxidized roGFP localized in keratinocyte mitochondria, but not when roGFP was localized in the cytosol. This suggests that significant amounts of the endogenous photosensitizers that mediate UVA induced oxidative stress are located in the mitochondria. UVR is the major environmental cause of skin aging and UVA mediated oxidative stress has been associated with the development of wrinkles in humans. Direct measurements of redox state in defined cell compartments of live animals should be a powerful and convenient tool for evaluating treatments that aim to modulate oxidative stress.

    DOI: 10.1038/jid.2013.428

    Web of Science

    PubMed

    researchmap

  • Inhibition of Endothelial p53 Improves Metabolic Abnormalities Related to Dietary Obesity Reviewed

    Masataka Yokoyama, Sho Okada, Atsushi Nakagomi, Junji Moriya, Ippei Shimizu, Aika Nojima, Yohko Yoshida, Harumi Ichimiya, Naomi Kamimura, Yoshio Kobayashi, Shigeo Ohta, Marcus Fruttiger, Guillermina Lozano, Tohru Minamino

    CELL REPORTS   7 ( 5 )   1691 - 1703   2014.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Accumulating evidence has suggested a role for p53 activation in various age-associated conditions. Here, we identified a crucial role of endothelial p53 activation in the regulation of glucose homeostasis. Endothelial expression of p53 was markedly upregulated when mice were fed a high-calorie diet. Disruption of endothelial p53 activation improved dietary inactivation of endothelial nitric oxide synthase that upregulated the expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha in skeletal muscle, thereby increasing mitochondrial biogenesis and oxygen consumption. Mice with endothelial cell-specific p53 deficiency fed a high-calorie diet showed improvement of insulin sensitivity and less fat accumulation, compared with control littermates. Conversely, upregulation of endothelial p53 caused metabolic abnormalities. These results indicate that inhibition of endothelial p53 could be a novel therapeutic target to block the vicious cycle of cardiovascular and metabolic abnormalities associated with obesity.

    DOI: 10.1016/j.celrep.2014.04.046

    Web of Science

    PubMed

    researchmap

  • Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice Reviewed

    Aika Nojima, Masakatsu Yamashita, Yohko Yoshida, Ippei Shimizu, Harumi Ichimiya, Naomi Kamimura, Yoshio Kobayashi, Shigeo Ohta, Naoaki Ishii, Tohru Minamino

    PLoS ONE   8 ( 7 )   e69178   2013.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    There is increasing evidence that nutrient-sensing machinery is critically involved in the regulation of aging. The insulin/insulin-like growth factor-1 signaling pathway is the best-characterized pathway with an influence on longevity in a variety of organisms, ranging from yeast to rodents. Reduced expression of the receptor for this pathway has been reported to prolong the lifespan
    however, the underlying mechanisms are largely unknown. Here we show that haploinsufficiency of Akt1 leads to an increase of the lifespan in mice. Akt1+/- mice had a lower body weight than their littermates with less fat mass and normal glucose metabolism. Ribosomal biogenesis and the mitochondrial DNA content were significantly reduced in these mice, along with a decrease of oxidative stress. Consistent with the results obtained in mice, inhibition of Akt-1 promoted longevity in nematodes (Caenorhabditis elegans), whereas activation of Akt-1 shortened the lifespan. Inhibition of Akt-1 led to a decrease of ribosomal gene expression and the mitochondrial DNA content in both human cells and nematodes. Moreover, deletion of ribosomal gene expression resulted in a decrease of the mitochondrial DNA content and normalized the lifespan shortened by Akt-1 activation in nematodes. These results suggest that an increase of mitochondrial amount and energy expenditure associated with enhanced protein synthesis accelerates both aging and the onset of age-associated diseases. © 2013 Nojima et al.

    DOI: 10.1371/journal.pone.0069178

    Scopus

    PubMed

    researchmap

  • ミトコンドリア機能と老化・疾患制御

    太田 成男, 上村 尚美, ウォルフ・アクレサンダー, 井内 勝哉, 佐野 元昭, 新村 健

    日本抗加齢医学会総会プログラム・抄録集   13回   163 - 163   2013.6

     More details

    Language:Japanese   Publisher:(一社)日本抗加齢医学会  

    researchmap

  • Involvement of PGC-1 alpha in the formation and maintenance of neuronal dendritic spines Reviewed

    Aiwu Cheng, Ruiqian Wan, Jenq-Lin Yang, Naomi Kamimura, Tae Gen Son, Xin Ouyang, Yongquan Luo, Eitan Okun, Mark P. Mattson

    NATURE COMMUNICATIONS   3   1250   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The formation, maintenance and reorganization of synapses are critical for brain development and the responses of neuronal circuits to environmental challenges. Here we describe a novel role for peroxisome proliferator-activated receptor gamma co-activator 1 alpha, a master regulator of mitochondrial biogenesis, in the formation and maintenance of dendritic spines in hippocampal neurons. In cultured hippocampal neurons, proliferator-activated receptor gamma coactivator 1 alpha overexpression increases dendritic spines and enhances the molecular differentiation of synapses, whereas knockdown of proliferator-activated receptor gamma coactivator 1 alpha inhibits spinogenesis and synaptogenesis. Proliferator-activated receptor gamma co-activator 1 alpha knockdown also reduces the density of dendritic spines in hippocampal dentate granule neurons in vivo. We further show that brain-derived neurotrophic factor stimulates proliferator-activated receptor gamma co-activator-1 alpha-dependent mitochondrial biogenesis by activating extracellular signal-regulated kinases and cyclic AMP response element-binding protein. Proliferator-activated receptor gamma co-activator-1 alpha knockdown inhibits brain-derived neurotrophic factor-induced dendritic spine formation without affecting expression and activation of the brain-derived neurotrophic factor receptor tyrosine receptor kinase B. Our findings suggest that proliferator-activated receptor gamma co-activator-1 alpha and mitochondrial biogenesis have important roles in the formation and maintenance of hippocampal dendritic spines and synapses.

    DOI: 10.1038/ncomms2238

    Web of Science

    PubMed

    researchmap

  • H-2 Gas Improves Functional Outcome After Cardiac Arrest to an Extent Comparable to Therapeutic Hypothermia in a Rat Model Reviewed

    Kei Hayashida, Motoaki Sano, Naomi Kamimura, Takashi Yokota, Masaru Suzuki, Yuichiro Maekawa, Akio Kawamura, Takayuki Abe, Shigeo Ohta, Keiichi Fukuda, Shingo Hori

    JOURNAL OF THE AMERICAN HEART ASSOCIATION   1 ( 5 )   e003459   2012.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Background-All clinical and biological manifestations related to postcardiac arrest (CA) syndrome are attributed to ischemia-reperfusion injury in various organs including brain and heart. Molecular hydrogen (H-2) has potential as a novel antioxidant. This study tested the hypothesis that inhalation of H-2 gas starting at the beginning of cardiopulmonary resuscitation (CPR) could improve the outcome of CA.
    Methods and Results-Ventricular fibrillation was induced by transcutaneous electrical epicardial stimulation in rats. After 5 minutes of the subsequent CA, rats were randomly assigned to 1 of 4 experimental groups at the beginning of CPR: mechanical ventilation (MV) with 2% N-2 and 98% O-2 under normothermia (37 degrees C), the control group; MV with 2% H-2 and 98% O-2 under normothermia; MV with 2% N-2 and 98% O-2 under therapeutic hypothermia (TH), 33 degrees C; and MV with 2% H-2 and 98% O-2 under TH. Mixed gas inhalation and TH continued until 2 hours after the return of spontaneous circulation (ROSC). H-2 gas inhalation yielded better improvement in survival and neurological deficit score (NDS) after ROSC to an extent comparable to TH. H-2 gas inhalation, but not TH, prevented a rise in left ventricular end-diastolic pressure and increase in serum IL-6 level after ROSC. The salutary impact of H-2 gas was at least partially attributed to the radical-scavenging effects of H-2 gas, because both 8-OHdG- and 4-HNE-positive cardiomyocytes were markedly suppressed by H-2 gas inhalation after ROSC.
    Conclusions-Inhalation of H-2 gas is a favorable strategy to mitigate mortality and functional outcome of post-CA syndrome in a rat model, either alone or in combination with TH.

    DOI: 10.1161/JAHA.112.003459

    Web of Science

    PubMed

    researchmap

  • Taurine Ameliorates Impaired the Mitochondrial Function and Prevents Stroke-like Episodes in Patients with MELAS Reviewed

    Mitsue Rikimaru, Yutaka Ohsawa, Alexander M. Wolf, Kiyomi Nishimaki, Harumi Ichimiya, Naomi Kamimura, Shin-ichiro Nishimatsu, Shigeo Ohta, Yoshihide Sunada

    INTERNAL MEDICINE   51 ( 24 )   3351 - 3357   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC INTERNAL MEDICINE  

    Objective Post-transcriptional taurine modification at the first anticodon ("wobble") nucleotide is deficient in A3243G-mutant mitochondrial (mt) tRNA(Leu(UUR)) of patients with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Wobble nucleotide modifications in tRNAs have recently been identified to be important in the accurate and efficient deciphering of codons. We herein examined whether taurine can alleviate mitochondrial dysfunction in patient-derived pathogenic cells and prevent clinical symptoms in MELAS patients.
    Methods and Results The addition of taurine to the culture media ameliorated the reduced oxygen consumption, decreased the mitochondrial membrane potential, and increased the oxidative stress in MELAS patient-derived cells. Moreover, high dose oral administration of taurine (0.25 g/kg/day) completely prevented stroke-like episodes in two MELAS patients for more than nine years.
    Conclusion Taurine supplementation may be a novel potential treatment option for preventing the stroke-like episodes associated with MELAS.

    DOI: 10.2169/internalmedicine.51.7529

    Web of Science

    PubMed

    researchmap

  • Overexpression of KLF15 Transcription Factor in Adipocytes of Mice Results in Down-regulation of SCD1 Protein Expression in Adipocytes and Consequent Enhancement of Glucose-induced Insulin Secretion Reviewed

    Tomoki Nagare, Hiroshi Sakaue, Michihiro Matsumoto, Yongheng Cao, Kenjiro Inagaki, Mashito Sakai, Yasuhiro Takashima, Kyoko Nakamura, Toshiyuki Mori, Yuko Okada, Yasushi Matsuki, Eijiro Watanabe, Kazutaka Ikeda, Ryo Taguchi, Naomi Kamimura, Shigeo Ohta, Ryuji Hiramatsu, Masato Kasuga

    JOURNAL OF BIOLOGICAL CHEMISTRY   286 ( 43 )   37458 - 37469   2011.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Kruppel-like factor 15 (KLF15), a member of the Kruppel-like factor family of transcription factors, has been found to play diverse roles in adipocytes in vitro. However, little is known of the function of KLF15 in adipocytes in vivo. We have now found that the expression of KLF15 in adipose tissue is down-regulated in obese mice, and we therefore generated adipose tissue-specific KLF15 transgenic (aP2-KLF15Tg) mice to investigate the possible contribution of KLF15 to various pathological conditions associated with obesity in vivo. The aP2-KLF15 Tg mice manifest insulin resistance and are resistant to the development of obesity induced by maintenance on a high fat diet. However, they also exhibit improved glucose tolerance as a result of enhanced insulin secretion. Furthermore, this enhancement of insulin secretion was shown to result from down-regulation of the expression of stearoyl-CoA desaturase 1 (SCD1) in white adipose tissue and a consequent reduced level of oxidative stress. This is supported by the findings that restoration of SCD1 expression in white adipose tissue of aP2-KLF15 Tg mice exhibited increased oxidative stress in white adipose tissue and reduced insulin secretion with hyperglycemia. Our data thus provide an example of cross-talk between white adipose tissue and pancreatic beta cells mediated through modulation of oxidative stress.

    DOI: 10.1074/jbc.M111.242651

    Web of Science

    PubMed

    researchmap

  • Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress Reviewed

    Yasuhiro Terasaki, Ikuroh Ohsawa, Mika Terasaki, Mikiko Takahashi, Shinobu Kunugi, Kang Dedong, Hirokazu Urushiyama, Shunsuke Amenomori, Mayuko Kaneko-Togashi, Naomi Kuwahara, Arimi Ishikawa, Naomi Kamimura, Shigeo Ohta, Yuh Fukuda

    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY   301 ( 4 )   L415 - L426   2011.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER PHYSIOLOGICAL SOC  

    Terasaki Y, Ohsawa I, Terasaki M, Takahashi M, Kunugi S, Dedong K, Urushiyama H, Amenomori S, Kaneko-Togashi M, Kuwahara N, Ishikawa A, Kamimura N, Ohta S, Fukuda Y. Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. Am J Physiol Lung Cell Mol Physiol 301: L415-L426, 2011. First published July 15, 2011; doi: 10.1152/ajplung.00008.2011.-Molecular hydrogen (H-2) is an efficient antioxidant that diffuses rapidly across cell membranes, reduces reactive oxygen species (ROS), such as hydroxyl radicals and peroxynitrite, and suppresses oxidative stress-induced injury in several organs. ROS have been implicated in radiation-induced damage to lungs. Because prompt elimination of irradiation-induced ROS should protect lung tissue from damaging effects of irradiation, we investigated the possibility that H-2 could serve as a radioprotector in the lung. Cells of the human lung epithelial cell line A549 received 10 Gy irradiation with or without H-2 treatment via H-2-rich PBS or medium. We studied the possible radioprotective effects of H-2 by analyzing ROS and cell damage. Also, C57BL/6J female mice received 15 Gy irradiation to the thorax. Treatment groups inhaled 3% H-2 gas and drank H-2-enriched water. We evaluated acute and late-irradiation lung damage after H-2 treatment. H-2 reduced the amount of irradiation-induced ROS in A549 cells, as shown by electron spin resonance and fluorescent indicator signals. H-2 also reduced cell damage, measured as levels of oxidative stress and apoptotic markers, and improved cell viability. Within 1 wk after whole thorax irradiation, immunohistochemistry and immunoblotting showed that H-2 treatment reduced oxidative stress and apoptosis, measures of acute damage, in the lungs of mice. At 5 mo after irradiation, chest computed tomography, Ashcroft scores, and type III collagen deposition demonstrated that H-2 treatment reduced lung fibrosis (late damage). This study thus demonstrated that H-2 treatment is valuable for protection against irradiation lung damage with no known toxicity.

    DOI: 10.1152/ajplung.00008.2011

    Web of Science

    PubMed

    researchmap

  • Caloric Restriction Primes Mitochondria for Ischemic Stress by Deacetylating Specific Mitochondrial Proteins of the Electron Transport Chain Reviewed

    Ken Shinmura, Kayoko Tamaki, Motoaki Sano, Naomi Nakashima-Kamimura, Alexander M. Wolf, Taku Amo, Shigeo Ohta, Yoshinori Katsumata, Keiichi Fukuda, Kyoko Ishiwata, Makoto Suematsu, Takeshi Adachi

    CIRCULATION RESEARCH   109 ( 4 )   396 - 406   2011.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Rationale: Caloric restriction (CR) confers cardioprotection against ischemia/reperfusion injury. However, the exact mechanism(s) underlying CR-induced cardioprotection remain(s) unknown. Recent evidence indicates that Sirtuins, NAD(+)-dependent deacetylases, regulate various favorable aspects of the CR response. Thus, we hypothesized that deacetylation of specific mitochondrial proteins during CR preserves mitochondrial function and attenuates production of reactive oxygen species during ischemia/reperfusion.
    Objective: The objectives of the present study were (1) to investigate the effect of CR on mitochondrial function and mitochondrial proteome and (2) to investigate what molecular mechanisms mediate CR-induced cardioprotection.
    Methods and Results: Male 26-week-old Fischer344 rats were randomly divided into ad libitum-fed and CR (40% reduction) groups for 6 months. No change was observed in basal mitochondrial function, but CR preserved postischemic mitochondrial respiration and attenuated postischemic mitochondrial H2O2 production. CR decreased the level of acetylated mitochondrial proteins that were associated with enhanced Sirtuin activity in the mitochondrial fraction. We confirmed a significant decrease in the acetylated forms of NDUFS1 and cytochrome bc1 complex Rieske subunit in the CR heart. Low-dose Resveratrol treatment mimicked the effect of CR on deacetylating them and attenuated reactive oxygen species production during anoxia/reoxygenation in cultured cardiomyocytes without changing the expression levels of manganese superoxide dismutase. Treatment with nicotinamide completely abrogated the effect of low-dose Resveratrol.
    Conclusions: These results strongly suggest that CR primes mitochondria for stress resistance by deacetylating specific mitochondrial proteins of the electron transport chain. Targeted deacetylation of NDUFS1 and/or Rieske subunit might have potential as a novel therapeutic approach for cardioprotection against ischemia/reperfusion. (Circ Res. 2011;109:396-406.)

    DOI: 10.1161/CIRCRESAHA.111.243097

    Web of Science

    PubMed

    researchmap

  • Molecular Hydrogen Improves Obesity and Diabetes by Inducing Hepatic FGF21 and Stimulating Energy Metabolism in db/db Mice Reviewed

    Naomi Kamimura, Kiyomi Nishimaki, Ikuroh Ohsawa, Shigeo Ohta

    OBESITY   19 ( 7 )   1396 - 1403   2011.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Recent extensive studies have revealed that molecular hydrogen (H-2) has great potential for improving oxidative stress-related diseases by inhaling H-2 gas, injecting saline with dissolved H-2, or drinking water with dissolved H-2 (H-2-water); however, little is known about the dynamic movement of H-2 in a body. First, we show that hepatic glycogen accumulates H-2 after oral administration of H-2-water, explaining why consumption of even a small amount of H-2 over a short span time efficiently improves various disease models. This finding was supported by an in vitro experiment in which glycogen solution maintained H-2. Next, we examined the benefit of ad libitum drinking H-2-water to type 2 diabetes using db/db obesity model mice lacking the functional leptin receptor. Drinking H-2-water reduced hepatic oxidative stress, and significantly alleviated fatty liver in db/db mice as well as high fat-diet-induced fatty liver in wild-type mice. Long-term drinking H-2-water significantly controlled fat and body weights, despite no increase in consumption of diet and water. Moreover, drinking H-2-water decreased levels of plasma glucose, insulin, and triglyceride, the effect of which on hyperglycemia was similar to diet restriction. To examine how drinking H-2-water improves obesity and metabolic parameters at the molecular level, we examined gene-expression profiles, and found enhanced expression of a hepatic hormone, fibroblast growth factor 21 (FGF21), which functions to enhance fatty acid and glucose expenditure. Indeed, H-2 stimulated energy metabolism as measured by oxygen consumption. The present results suggest the potential benefit of H-2 in improving obesity, diabetes, and metabolic syndrome.

    DOI: 10.1038/oby.2011.6

    Web of Science

    PubMed

    researchmap

  • Molecular hydrogen protects chondrocytes from oxidative stress and indirectly alters gene expressions through reducing peroxynitrite derived from nitric oxide Reviewed

    Teruyasu Hanaoka, Naomi Kamimura, Takashi Yokota, Shinro Takai, Shigeo Ohta

    Medical Gas Research   1 ( 1 )   18   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BioMed Central Ltd.  

    Background: Molecular hydrogen (H&lt
    inf&gt
    2&lt
    /inf&gt
    ) functions as an extensive protector against oxidative stress, inflammation and allergic reaction in various biological models and clinical tests
    however, its essential mechanisms remain unknown. H&lt
    inf&gt
    2&lt
    /inf&gt
    directly reacts with the strong reactive nitrogen species peroxynitrite (ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    ) as well as hydroxyl radicals (OH), but not with nitric oxide radical (NO). We hypothesized that one of the H &lt
    inf&gt
    2&lt
    /inf&gt
    functions is caused by reducing cellular ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    , which is generated by the rapid reaction of NO with superoxides (O&lt
    inf&gt
    2&lt
    /inf&gt
    &lt
    sup&gt
    -&lt
    /sup&gt
    ). To verify this hypothesis, we examined whether H&lt
    inf&gt
    2&lt
    /inf&gt
    could restore cytotoxicity and transcriptional alterations induced by ONOO &lt
    sup&gt
    -&lt
    /sup&gt
    derived from NO in chondrocytes. Methods. We treated cultured chondrocytes from porcine hindlimb cartilage or from rat meniscus fibrecartilage with a donor of NO, S-nitroso-N-acetylpenicillamine (SNAP) in the presence or absence of H&lt
    inf&gt
    2&lt
    /inf&gt
    . Chondrocyte viability was determined using a LIVE/DEAD Viability/Cytotoxicity Kit. Gene expressions of the matrix proteins of cartilage and the matrix metalloproteinases were analyzed by reverse transcriptase-coupled real-time PCR method. Results: SNAP treatment increased the levels of nitrated proteins. H&lt
    inf&gt
    2&lt
    /inf&gt
    decreased the levels of the nitrated proteins, and suppressed chondrocyte death. It is known that the matrix proteins of cartilage (including aggrecan and type II collagen) and matrix metalloproteinases (such as MMP3 and MMP13) are down- and up-regulated by ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    , respectively. H&lt
    inf&gt
    2&lt
    /inf&gt
    restoratively increased the gene expressions of aggrecan and type II collagen in the presence of H&lt
    inf&gt
    2&lt
    /inf&gt
    . Conversely, the gene expressions of MMP3 and MMP13 were restoratively down-regulated with H&lt
    inf&gt
    2&lt
    /inf&gt
    . Thus, H&lt
    inf&gt
    2&lt
    /inf&gt
    acted to restore transcriptional alterations induced by ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    . Conclusions: These results imply that one of the functions of H&lt
    inf&gt
    2&lt
    /inf&gt
    exhibits cytoprotective effects and transcriptional alterations through reducing ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    . Moreover, novel pharmacological strategies aimed at selective removal of ONOO&lt
    sup&gt
    -&lt
    /sup&gt
    may represent a powerful method for preventive and therapeutic use of H&lt
    inf&gt
    2&lt
    /inf&gt
    for joint diseases. © 2011 Hanaoka et al
    licensee BioMed Central Ltd.

    DOI: 10.1186/2045-9912-1-18

    Scopus

    PubMed

    researchmap

  • Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats Reviewed

    Ruiqian Wan, Ismayil Ahmet, Martin Brown, Aiwu Cheng, Naomi Kamimura, Mark Talan, Mark P. Mattson

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY   21 ( 5 )   413 - 417   2010.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    It has been reported that dietary energy restriction, including intermittent fasting (IF), can protect heart and brain cells against injury and improve functional outcome in animal models of myocardial infarction (MI) and stroke. Here we report that IF improves glycemic control and protects the myocardium against ischemia-induced cell damage and inflammation in rats. Echocardiographic analysis of heart structural and functional variables revealed that IF attenuates the growth-related increase in posterior ventricular wall thickness, end systolic and diastolic volumes, and reduces the ejection fraction. The size of the ischemic infarct 24 h following permanent ligation of a coronary artery was significantly smaller, and markers of inflammation (infiltration of leukocytes in the area at risk and plasma IL-6 levels) were less, in IF rats compared to rats on the control diet. IF resulted in increased levels of circulating adiponectin prior to and after MI. Because recent studies have shown that adiponectin can protect the heart against ischemic injury, our findings suggest a potential role for adiponectin as a mediator of the cardioprotective effect of IF. Published by Elsevier Inc.

    DOI: 10.1016/j.jnutbio.2009.01.020

    Web of Science

    PubMed

    researchmap

  • Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice Reviewed

    Naomi Nakashima-Kamimura, Takashi Mori, Ikuroh Ohsawa, Sadamitsu Asoh, Shigeo Ohta

    CANCER CHEMOTHERAPY AND PHARMACOLOGY   64 ( 4 )   753 - 761   2009.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Cisplatin is a widely used anti-cancer drug in the treatment of a wide range of tumors; however, its application is limited by nephrotoxicity, which is affected by oxidative stress. We have reported that molecular hydrogen (H(2)) acts as an efficient antioxidant (Ohsawa et al. in Nat Med 13:688-694, 2007). Here we show that hydrogen efficiently mitigates the side effects of cisplatin by reducing oxidative stress.
    Mice were administered cisplatin followed by inhaling hydrogen gas (1% H(2) in air). Furthermore, instead of inhaling hydrogen gas, we examined whether drinking water containing hydrogen (hydrogen water; 0.8 mM H(2) in water) is applicable by examining oxidative stress, mortality, and body-weight loss. Nephrotoxicity was assessed by morphological changes, serum creatinine and blood urea nitrogen (BUN) levels.
    Inhalation of hydrogen gas improved mortality and body-weight loss caused by cisplatin, and alleviated nephrotoxicity. Hydrogen was detected in blood when hydrogen water was placed in the stomach of a rat. Consuming hydrogen water ad libitum also reduced oxidative stress, mortality, and body-weight loss induced by cisplatin in mice. Hydrogen water improved metamorphosis accompanying decreased apoptosis in the kidney, and nephrotoxicity as assessed by serum creatinine and BUN levels. Despite its protective effects against cisplatin-induced toxicity, hydrogen did not impair anti-tumor activity of cisplatin against cancer cell lines in vitro and tumor-bearing mice in vivo.
    Hydrogen has potential for improving the quality of life of patients during chemotherapy by efficiently mitigating the side effects of cisplatin.

    DOI: 10.1007/s00280-008-0924-2

    Web of Science

    PubMed

    researchmap

  • Consumption of Molecular Hydrogen Prevents the Stress-Induced Impairments in Hippocampus-Dependent Learning Tasks during Chronic Physical Restraint in Mice Reviewed

    Kazufumi Nagata, Naomi Nakashima-Kamimura, Toshio Mikami, Ikuroh Ohsawa, Shigeo Ohta

    NEUROPSYCHOPHARMACOLOGY   34 ( 2 )   501 - 508   2009.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    We have reported that hydrogen (H(2)) acts as an efficient antioxidant by gaseous rapid diffusion. When water saturated with hydrogen ( hydrogen water) was placed into the stomach of a rat, hydrogen was detected at several mu M level in blood. Because hydrogen gas is unsuitable for continuous consumption, we investigated using mice whether drinking hydrogen water ad libitum, instead of inhaling hydrogen gas, prevents cognitive impairment by reducing oxidative stress. Chronic physical restraint stress to mice enhanced levels of oxidative stress markers, malondialdehyde and 4-hydroxy-2-nonenal, in the brain, and impaired learning and memory, as judged by three different methods: passive avoidance learning, object recognition task, and the Morris water maze. Consumption of hydrogen water ad libitum throughout the whole period suppressed the increase in the oxidative stress markers and prevented cognitive impairment, as judged by all three methods, whereas hydrogen water did not improve cognitive ability when no stress was provided. Neural proliferation in the dentate gyrus of the hippocampus was suppressed by restraint stress, as observed by 5-bromo-2'-deoxyuridine incorporation and Ki-67 immunostaining, proliferation markers. The consumption of hydrogen water ameliorated the reduced proliferation although the mechanistic link between the hydrogen-dependent changes in neurogenesis and cognitive impairments remains unclear. Thus, continuous consumption of hydrogen water reduces oxidative stress in the brain, and prevents the stress-induced decline in learning and memory caused by chronic physical restraint. Hydrogen water may be applicable for preventive use in cognitive or other neuronal disorders.

    DOI: 10.1038/npp.2008.95

    Web of Science

    PubMed

    researchmap

  • Prevention of chemotherapy-induced alopecia by the anti-death FNK protein Reviewed

    Naomi Nakashima-Kamimura, Kiyomi Nishimaki, Takashi Mori, Sadamitsu Asoh, Shigeo Ohta

    LIFE SCIENCES   82 ( 3-4 )   218 - 225   2008.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Many anticancer drugs attack rapidly dividing cells, including not only malignant cells but also hair follicle cells, and induce alopecia. Chemotherapy-induced alopecia (CIA) is an emotionally distressing side effect of cancer chemotherapy. There is currently no useful preventive therapy for CIA. We have previously constructed anti-death rFNK protein from rat Bcl-x(L) by site-directed mutagenesis to strengthen cytoprotective activity. When fused to the protein transduction domain (PTD) of HIV/Tat, the fusion protein PTD (TAT)-rFNK successfully entered cells from the outside in vitro and in vivo to exhibit anti-death activity against apoptosis and necrosis. Here, we show that topical application of FNK protected against CIA in a newborn rat model. The protective activity against hair-loss was observed in 30-1000 nM TAT-rFNK administrative groups in a dose-dependent manner. Furthermore, a human version of FNK (hFNK) fused to other PTD peptides exhibited a protective ability. These results suggest that PTD-FNK possesses protective activity against CIA and is not restricted to a sequence of PTD peptides or species of FNK. Thus, PTD-FNK represents potential to develop a useful method for preventing CIA in cancer patients. (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.lfs.2007.11.011

    Web of Science

    PubMed

    researchmap

  • Compensatory change of interacting amino acids in the coevolution of transcriptional coactivator MBF1 and TATA-box-binding protein Reviewed

    Qing-Xin Liu, Naomi Nakashima-Kamimura, Kazuho Ikeo, Susumu Hirose, Takashi Gojobori

    MOLECULAR BIOLOGY AND EVOLUTION   24 ( 7 )   1458 - 1463   2007.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    To elucidate the transcriptional regulation in eukaryotic genome network, it is important to understand coevolution of transcription factors, transcriptional coactivators, and TATA-box-binding protein (TBP). In this study, coevolution of transcriptional coactivator multiprotein-bridging factor 1 and its interacting target TBP was first evaluated experimentally by examining if compensatory amino acid changes took place at interacting sites of both proteins. The experiments were conducted by identifying interaction sites and comparing the amino acids at these sites among different organisms. Here, we provide evidence for compensatory changes of transcription coactivator and its interacting target, presenting the 1st report that transcription coactivator may have undergone coevolution with TBP.

    DOI: 10.1093/molbev/msm073

    Web of Science

    PubMed

    researchmap

  • MIDAS/GPP34, a nuclear gene product, regulates total mitochondrial mass in response to mitochondrial dysfunction Reviewed

    N Nakashima-Kamimura, S Asoh, Y Ishibashi, Y Mukai, Y Shidara, H Oda, K Munakata, Y Goto, S Ohta

    JOURNAL OF CELL SCIENCE   118 ( 22 )   5357 - 5367   2005.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:COMPANY OF BIOLOGISTS LTD  

    To investigate the regulatory system in mitochondrial biogenesis involving crosstalk between the mitochondria and nucleus, we found a factor named MIDAS (mitochondrial DNA absence sensitive factor) whose expression was enhanced by the absence of mitochondrial DNA (mtDNA). In patients with mitochondrial diseases, MIDAS expression was increased only in dysfunctional muscle fibers. A majority of MIDAS localized to mitochondria with a small fraction in the Golgi apparatus in HeLa cells. To investigate the function of MIDAS, we stably transfected HeLa cells with an expression vector carrying MIDAS cDNA or siRNA. Cells expressing the MIDAS protein and the siRNA constitutively showed an increase and decrease in the total mass of mitochondria, respectively, accompanying the regulation of a mitochondria-specific phospholipid, cardiolipin. In contrast, amounts of the mitochondrial DNA, RNA and proteins did not depend upon MMAS. Thus, MIDAS is involved in the regulation of mitochondrial lipids, leading to increases of total mitochondrial mass in response to mitochondrial dysfunction.

    DOI: 10.1242/jcs.02645

    Web of Science

    PubMed

    researchmap

  • Fidelity of DNA polymerase delta holoenzyme from Saccharomyces cerevisiae: The sliding clamp proliferating cell nuclear antigen decreases its fidelity Reviewed

    K Hashimoto, K Shimizu, N Nakashima, A Sugino

    BIOCHEMISTRY   42 ( 48 )   14207 - 14213   2003.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    DNA polymerases delta and epsilon (pol delta and epsilon) are the two major replicative polymerases in the budding yeast Saccharomyces cerevisiae. The fidelity of pol delta is influenced by its 3'-5' proofreading exonuclease activity, which corrects misinsertion errors, and by enzyme cofactors. PCNA is a pol delta cofactor, called the sliding clamp, which increases the processivity of pol delta holoenzyme. This study measures the fidelity of 3'-5' exonuclease-proficient and -deficient pol delta holoenzyme using a synthetic 30mer primer/ 100mer template in the presence and absence of PCNA. Although PCNA increases pol delta processivity, the presence of PCNA decreased pol delta fidelity 2-7-fold. In particular, wild-type pol delta demonstrated the following nucleotide substitution efficiencies for mismatches in the absence of PCNA: G(.)G, 0.728 x 10(-4); T(.)G, 1.82 x 10(-4); A(.)G, <0.01 x 10(-4). In the presence of PCNA these values increased as follows: G(.)G, 1.30 x 10(-4); T(.)G, 2.62 x 10(-4); A(.)G, 0.074 x 10(-4). A similar but smaller effect was observed for exonuclease-deficient pol delta (i.e., 2-4-fold increase in nucleotide substitution efficiencies in the presence of PCNA). Thus, the fidelity of wild-type pol delta in the presence of PCNA is more than 2 orders of magnitude lower than the fidelity of wild-type pol is holoenzyme and is comparable to the fidelity of exonuclease-deficient pol epsilon holoenzyme.

    DOI: 10.1021/bi0348359

    Web of Science

    PubMed

    researchmap

  • The DNA polymerase domain of pole is required for rapid, efficient, and highly accurate chromosomal DNA replication, telomere length maintenance, and normal cell senescence in Saccharomyces cerevisiae Reviewed

    T Ohya, Y Kawasaki, SI Hiraga, S Kanbara, K Nakajo, N Nakashima, A Suzuki, A Sugino

    JOURNAL OF BIOLOGICAL CHEMISTRY   277 ( 31 )   28099 - 28108   2002.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Saccharomyces cerevisiae POL2 encodes the catalytic subunit of DNA polymerase epsilon. This study investigates the cellular functions performed by the polymerase domain of Pol2p and its role in DNA metabolism. The pol2-16 mutation has a deletion in the catalytic domain of DNA polymerase a that eliminates its polymerase and exonuclease activities. It is a viable mutant, which displays temperature sensitivity for growth and a defect in elongation step of chromosomal DNA replication even at permissive temperatures. This mutation is synthetic lethal in combination with temperature-sensitive mutants or the 3'- to 5'-exonuclease-deficient mutant of DNA polymerase delta in a haploid cell. These results suggest that the catalytic activity of DNA polymerase a participates in the same pathway as DNA polymerase delta, and this is consistent with the observation that DNA polymerases delta and epsilon colocalize in some punctate foci on yeast chromatids during S phase. The pol2-16 mutant senesces more rapidly than wild type strain and also has shorter telomeres. These results indicate that the DNA polymerase domain of Po12p is required for rapid, efficient, and highly accurate chromosomal DNA replication in yeast.

    DOI: 10.1074/jbc.M111573200

    Web of Science

    PubMed

    researchmap

  • The fifth essential DNA polymerase phi in Saccharomyces cerevisiae is localized to the nucleolus and plays an important role in synthesis of rRNA Reviewed

    K Shimizu, Y Kawasaki, SI Hiraga, M Tawaramoto, N Nakashima, A Sugino

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   99 ( 14 )   9133 - 9138   2002.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    We report that POL5 encodes the fifth essential DNA polymerase in Saccharomyces cerevisiae. Pol5p was identified and purified from yeast cell extracts and is an aphidicolin-sensitive DNA polymerase that is stimulated by yeast proliferating cell nuclear antigen (PCNA). Thus, we named Pol5p DNA polymerase phi. Temperature-sensitive pol5-1similar to-3 mutants did not arrest at G(2)/M at the restrictive temperature. Furthermore, the polymerase active-site mutant POL5dn gene complements the lethality of Deltapol5. These results suggest that the polymerase activity of Pol5p is not required for the in vivo function of Pol5p. rRNA synthesis was severely inhibited at the restrictive temperature in the temperature-sensitive pol5-3 mutant cells, suggesting that an essential function of Pol5p is rRNA synthesis. Pol5p is localized exclusively to the nucleolus and binds near or at the enhancer region of rRNA-encoding DNA repeating units.

    DOI: 10.1073/pnas.142277999

    Web of Science

    PubMed

    researchmap

  • DNA polymerase epsilon encoded by cdc20(+) is required for chromosomal DNA replication in the fission yeast Schizosaccharomyces pombe Reviewed

    A Sugino, T Ohara, J Sebastian, N Nakashima, H Araki

    GENES TO CELLS   3 ( 2 )   99 - 110   1998.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Background: DNA polymerase II (PolII), the homologue of mammalian DNA polymerase epsilon, is essential for chromosomal DNA replication in the budding yeast Saccharomyces cerevisiae and also participates in S-phase checkpoint control. An important issue is whether chromosomal DNA replication in other eukaryotes, including the fission yeast Schizosaccharomyces pombe-in which the characteristics of replication origins are poorly defined-also requires DNA polymerase E. It has been shown that DNA polymerase epsilon is not required for the in vitro replication of SV40 DNA by human cell extracts.
    Results: We have cloned and sequenced S. pombe pol2(+), which is identical to the cell-cycle gene cdc20(+), encoding the catalytic polypeptide of DNA polymerase epsilon (Pol epsilon). The predicted amino acid sequence of Pol epsilon is highly homologous to that of S. cerevisiae PolII and human Pol epsilon. Consistent with this, the Pol epsilon polypeptide was recognized by polyclonal antibodies against S. cerevisiae PolII holoenzyme (PolII(star)). The terminal morphology of cells containing the disrupted pol2 gene was similar to that of DNA replication mutant cells and cdc20 mutant cells. Furthermore, the Pol epsilon activity from temperature-sensitive S. pombe cdc20 mutant cells was temperature-sensitive, and chromosomal DNA replication in the mutant cells was inhibited at the restrictive temperatures.
    Conclusion: These data strongly suggest that Pol epsilon is required for normal chromosomal DNA replication in S. pombe, as is PolII in S. cerevisiae. Thus, eukaryotic chromosomal DNA is replicated differently from that of viral SV40 DNA.

    DOI: 10.1046/j.1365-2443.1998.00169.x

    Web of Science

    PubMed

    researchmap

  • The second subunit of DNA polymerase III (delta) is encoded by the HYS2 gene in Saccharomyces cerevisiae Reviewed

    K Hashimoto, N Nakashima, T Ohara, S Maki, A Sugino

    NUCLEIC ACIDS RESEARCH   26 ( 2 )   477 - 485   1998.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    DNA polymerase III (delta) of Saccharomyces cerevisiae is purified as a complex of at least two polypeptides with molecular masses of 125 and 55 kDa as judged by SDS-PAGE. In this paper we determine partial amino acid sequences of the 125 and 55 kDa polypeptides and find that they match parts of the amino acid sequences predicted from the nucleotide sequence of the CDC2 and HYS2 genes respectively, We also show by Western blotting that Hys2 protein co-purifies with DNA polymerase III activity as well as Cdc2 polypeptide. The complex form of DNA polymerase III activity could not be detected in thermosensitive hys2 mutant cell extracts, although another form of DNA polymerase III was found, This form of DNA polymerase III, which could also be detected in wild-type extracts, was not associated with Hys2 protein and was not stimulated by addition of proliferating cell nuclear antigen (PCNA), replication factor A (RF-A) or replication factor C (RF-C), The temperature-sensitive growth phenotype of hys2-1 and hys2-2 mutations could be suppressed by the CDC2 gene on a multicopy plasmid, These data suggest that the 55 kDa polypeptide encoded by the HYS2 gene is one of the subunits of DNA polymerase III complex in S.cerevisiae and is required for highly processive DNA synthesis catalyzed by DNA polymerase III in the presence of PCNA, RF-A and RF-C.

    DOI: 10.1093/nar/26.2.477

    Web of Science

    PubMed

    researchmap

  • Cell cycle control in fission yeast and mammals: Identification of new regulatory mechanisms Reviewed

    H Okayama, A Nagata, S Jinno, H Murakami, K Tanaka, N Nakashima

    ADVANCES IN CANCER RESEARCH, VOL 69   69   17 - 62   1996

     More details

    Language:English   Publisher:ACADEMIC PRESS INC  

    DOI: 10.1016/s0065-230x(08)60859-3

    Web of Science

    PubMed

    researchmap

  • FISSION YEAST REP2 IS A PUTATIVE TRANSCRIPTIONAL ACTIVATOR SUBUNIT FOR THE CELL-CYCLE START FUNCTION OF RES2-CDC1O Reviewed

    N NAKASHIMA, K TANAKA, S STURM, H OKAYAMA

    EMBO JOURNAL   14 ( 19 )   4794 - 4802   1995.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    In the yeast cell cycle 'start' requires sets of the Cdc10/ SWI family of transcriptional factors which activate the MCB cis elements contained in genes essential for S phase progression. Fission yeast possess two such overlapping systems, Res1-Cdc10 and Res2-Cdc10, both of which act to start the mitotic and meiotic cycles, We have recently isolated rep2(+) as a multicopy suppressor of a temperature-sensitive cdc10 mutant which encodes a zinc finger protein. Here we show that the Rep2 zinc finger protein is an essential component of the active Res2-Cdc10 transcriptional regulator complex and likely to play a role in the control of cell cycle 'start'. Our data suggest that Rep2 is a transcriptional activator subunit which interacts with the MCB binding subunit complex formed by Res2 and Cdc10.

    Web of Science

    PubMed

    researchmap

  • HAC1 - A NOVEL YEAST BZIP PROTEIN-BINDING TO THE CRE MOTIF IS A MULTICOPY SUPPRESSOR FOR CDC10 MUTANT OF SCHIZOSACCHAROMYCES-POMBE Reviewed

    H NOJIMA, SH LEEM, H ARAKI, A SAKAI, N NAKASHIMA, Y KANAOKA, Y ONO

    NUCLEIC ACIDS RESEARCH   22 ( 24 )   5279 - 5288   1994.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS UNITED KINGDOM  

    We cloned by phenotypic complementation a novel Saccharomyces cerevisiae's multicopy suppressor of the Schizosaccharomyces pombe cdc10-129 mutant which we call HAC1, an acronym of 'homologous to ATF/CREB 1'. It encodes a bZIP (basic-leucine zipper) protein of 230 amino acids with close homology to the mammalian ATF/CREB transcription factor and gel-retardation assays showed that it binds specifically to the CRE motif. HAC1 is not essential for viability. However, the had disruptant becomes caffeine sensitive, which is suppressed by multicopy expression of the yeast PDE2 (Phosphodiesterase 2) gene. Although the mRNA level of HAC1 is almost constitutive throughout the cell cycle, it fluctuates during meiosis. The upstream region of the HAC1 gene contains a T4C site, a URS (upstream repression sequence) and a TR (T-rich) box-like sequence, which reside upstream of many meiotic genes. These results suggest that HAC1 may also be one of the meiotic genes.

    DOI: 10.1093/nar/22.24.5279

    Web of Science

    PubMed

    researchmap

  • YOLK VITRONECTIN - PURIFICATION AND DIFFERENCES FROM ITS BLOOD HOMOLOG IN MOLECULAR-SIZE, HEPARIN BINDING, COLLAGEN BINDING, AND BOUND CARBOHYDRATE Reviewed

    Y NAGANO, T HAMANO, N NAKASHIMA, M ISHIKAWA, K MIYAZAKI, M HAYASHI

    JOURNAL OF BIOLOGICAL CHEMISTRY   267 ( 34 )   24863 - 24870   1992.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    This is the first report on a unique vitronectin molecule, yolk vitronectin, which is similar to its blood homologue in cell spreading activity but different in molecular size, bound carbohydrate, and heparin and collagen binding activity. Yolk vitronectin was purified 2,500-fold from chick egg yolk by a combination of hydroxylapatite, DEAE-cellulose, and anti-vitronectin-Sepharose column chromatographies. In SDS-polyacrylamide gel electrophoresis under reducing conditions, yolk vitronectin was separated into 54- and 45-kDa bands, which are 16 and 25 kDa smaller, respectively, than the 70-kDa major band of chick blood vitronectin. The 54-kDa band shares the same NH2-terminal sequence as chick blood vitronectin. In contrast, the NH2-terminal sequence of the 45-kDa band is somewhat homologous with the internal sequences of mammalian vitronectins beginning at the 50th amino acid from the NH2 terminus. The bound carbohydrate of the 54- and 45-kDa species of yolk vitronectin is similar to, but distinct from, that of blood vitronectin. Unlike blood vitronectin, yolk vitronectin cannot bind to either heparin or collagen.

    Web of Science

    PubMed

    researchmap

  • VITRONECTIN DIVERSITY IN EVOLUTION BUT UNIFORMITY IN LIGAND-BINDING AND SIZE OF THE CORE POLYPEPTIDE Reviewed

    N NAKASHIMA, K MIYAZAKI, M ISHIKAWA, T YATOHGO, H OGAWA, H UCHIBORI, MATSUMOTO, I, N SENO, M HAYASHI

    BIOCHIMICA ET BIOPHYSICA ACTA   1120 ( 1 )   1 - 10   1992.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    We isolated vitronectins from the plasma or sera of 14 animal species including mouse and rat by heparin affinity chromatography. They cross-reacted with anti-vitronectin antibody and their amino terminal sequences showed strong homology. They also promoted spreading of BHK cells and were bound to heparin and collagen in the same way. Therefore, these properties appear to be essential for vitronectin function. However, the apparent molecular weights of these vitronectins varied considerably from 59 to 78 kDa in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). In addition, the number of bands also varied from 1 to 3. To search for the uniformity of vitronectin polypeptide, vitronectins were deglycosylated and examined by Ferguson plot analysis. The size of the polypeptide portion of vitronectins was estimated to range from 40 to 57 kDa which was 19-26 kDa smaller than original values. Supposing a possible cleavage site at 5-13 kDa far from the carboxyl terminus, all vitronectin polypeptides were speculated to be synthesized de novo in the size range of 50-57 kDa. Proteins reacting with anti-vitronectin antibody were also detected on the immunoblot of 13 more species including Drosophila and Physarum. Almost all of these vitronectin-like proteins showed marked species-specific variations in their apparent molecular weights from 51 to 96 kDa in SDS-PAGE.

    DOI: 10.1016/0167-4838(92)90417-c

    Web of Science

    PubMed

    researchmap

▼display all

Misc.

  • 血中のPD-1結合能を有する可溶性PD-L1 を用いた非小細胞肺癌の 免疫チェックポイント阻害薬の効果予測

    柏田 健, 西槇 貴代美, 上村 尚美, 清家 正博, 弦間 昭彦, 岩井 佳子

    第78回日本癌学会総会   2019.9

     More details

  • PD-1結合能を有する可溶性PD-L1(sPD-L1)を検出するELISA系を用いた、非小細胞肺癌への免疫チェックポイント阻害剤の効果予測(Soluble PD-L1 with PD-1-binding capacity as a biomarker for anti-PD-1/PD-L1 therapy for non-small cell lung cancer)

    柏田 建, 西槇 貴代美, 上村 尚美, 清家 正博, 弦間 昭彦, 岩井 佳子

    日本癌学会総会記事   78回   P - 2309   2019.9

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • 青色光照射後の酸化ストレスによるマウス網膜組織への影響

    横田 隆, Alexander Wolf, 上村 尚美, 小原澤 英彰, 五十嵐 勉, 高橋 浩, 太田 成男

    生命科学系学会合同年次大会   2017年度   [2P - 1035]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    researchmap

  • in vivo酸化ストレスモニターマウスを用いた糖尿病モデルマウスの酸化ストレス測定と分子状水素の効果

    上村尚美, WOLF Alexander, 西槙貴代美, 横田隆, 一宮治美, 井内勝哉, 太田成男

    日本抗加齢医学会総会プログラム・抄録集   17th   2017

  • ペルオキシナイトライト産生酸化ストレス傷害に対する水素分子(H2)のラット網膜保護効果

    横田 隆, 上村 尚美, 五十嵐 勉, 高橋 浩, 小原澤 英彰, 太田 成男

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [2P1207] - [2P1207]   2015.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • Response to Letter Regarding Article, "Hydrogen Inhalation During Normoxic Resuscitation Improves Neurological Outcome in a Rat Model of Cardiac Arrest Independently of Targeted Temperature Management"

    Kei Hayashida, Motoaki Sano, Naomi Kamimura, Takashi Yokota, Masaru Suzuki, Shigeo Ohta, Keiichi Fukuda, Shingo Hori

    CIRCULATION   132 ( 11 )   E148 - E148   2015.9

     More details

    Language:English   Publishing type:Rapid communication, short report, research note, etc. (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    DOI: 10.1161/CIRCULATIONAHA.115.016785

    Web of Science

    researchmap

  • 分子状水素はフリーラジカル連鎖反応で生じる脂質メディエーターを調節して遺伝子発現を制御する

    井内勝哉, 井本明美, 井本明美, 西槙貴代美, 一宮治美, LEE Hyunjin, 横田隆, 上村尚美, 太田成男

    日本生化学会大会(Web)   88th   2015

  • TBHPを用いた酸化ストレス誘導性の細胞死に対する分子状水素の保護作用

    井内勝哉, 井本明美, 井本明美, 西槙貴代美, 一宮治美, 李げんしん, 横田隆, 上村尚美, 太田成男

    日本Cell Death学会学術集会プログラム抄録集   24th   2015

  • アルツハイマーモデルマウスに対する骨髄単核球移植の認知機能改善効果(第2報)

    金丸 拓也, 上村 尚美, 井内 勝哉, 西槙 貴代美, 横田 隆, 高見 新也, 赤芝 洋紀, 志鷹 義嗣, 桂 研一郎, 太田 成男, 片山 泰朗

    臨床神経学   54 ( Suppl )   S135   2014.12

     More details

    Language:Japanese   Publishing type:Meeting report  

    researchmap

  • Inhalation of H2 Gas Starting After Resuscitation Under Normoxia Improves Neurological Outcomes in a Rat Cardiac Arrest Model

    Kei Hayashida, Motoaki Sano, Naomi Kamimura, Takashi Yokota, Masaru Suzuki, Shigeo Ohta, Keiichi Fukuda, Shingo Hori

    CIRCULATION   130   2014.11

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 血管内皮細胞p53の抑制は食餌性肥満における代謝異常を改善する

    横山 真隆, 岡田 将, 中込 敦士, 森谷 純治, 野島 愛佳, 小林 欣夫, 清水 逸平, 吉田 陽子, 南野 徹, 一宮 治美, 上村 尚美, 太田 成男, Fruttiger Marcus, Lozano Guillermina

    代謝異常治療研究基金研究業績集   41   21 - 30   2014.1

     More details

    Language:Japanese   Publisher:(一財)代謝異常治療研究基金  

    血管内皮細胞p53の抑制は食餌性肥満における代謝異常を改善するか検討した。野生型マウスに高脂肪高蔗糖食を投与して食餌性肥満モデルを作製し、大動脈・肺/骨格筋の血管内皮細胞を評価した。これらのマウスを用いて標本切片の染色・蛋白抽出やRNA抽出による分子発現確認を行った。次に血管内皮細胞p53の役割を評価するために血管内皮細胞特異的p53ノックアウトマウスを作製した。高カロリー食負荷によって血管内皮細胞でのGlut1発現がp53活性化に伴って減少し、この変化がp53ノックアウトによって消失するとともに骨格筋への糖取り込みが亢進した。p53はPTEN並びにGlut1の発現を調節することで糖代謝に関与していることが示唆された。

    researchmap

  • ミトコンドリア活性酸素の実時間計測,酸化ストレス亢進マウスの作製,新概念の抗酸化物質としての水素

    太田成男, 上村尚美, WOLF Alexander M., 井内勝哉, 西槙貴代美, 一宮治美, 横田隆, 中嶋裕也

    基礎老化研究   38 ( 3 )   2014

  • Alzheimerモデルマウスに対する骨髄単核球移植の認知機能改善効果

    金丸 拓也, 上村 尚美, 井内 勝哉, 西槇 貴代美, 横田 隆, 高見 新也, 赤芝 洋紀, 志鷹 義嗣, 桂 研一郎, 太田 成男, 片山 泰朗

    臨床神経学   53 ( 12 )   1483   2013.12

     More details

    Language:Japanese   Publishing type:Meeting report  

    researchmap

  • Inhalation of H2 in the Absence of Hyperoxia Starting after Rosc Improves Neurologic Outcomes and Survival in a Rat Model Following Resuscitation from Cardiac Arrest

    Kei Hayashida, Motoaki Sano, Naomi Kamimura, Takashi Yokota, Shigeo Ohta, Keiichi Fukuda, Shingo Hori

    CIRCULATION   128 ( 22 )   2013.11

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • Alzheimer病モデルマウスに対する骨髄単核球移植の認知機能改善効果

    金丸 拓也, 上村 尚美, 井内 勝哉, 西槇 貴代美, 横田 隆, 高見 新也, 赤芝 洋紀, 志鷹 義嗣, 桂 研一郎, 太田 成男, 片山 泰朗

    神経治療学   30 ( 5 )   685   2013.9

     More details

    Language:Japanese   Publishing type:Meeting report  

    researchmap

  • アルツハイマー病モデルマウスに対する骨髄単核球移植の予防・治療効果

    上村尚美, 金丸拓也, 金丸拓也, 横田隆, 井内勝哉, 西槙貴代美, 高見新也, 赤芝洋紀, 志鷹義嗣, 桂研一郎, 片山泰朗, 太田成男

    日本分子生物学会年会プログラム・要旨集(Web)   36th   2013

  • ヒト変異APP高発現マウスと酸化ストレス亢進マウスとの掛け合わせマウスの解析

    上村尚美, 金丸拓也, 金丸拓也, 横田隆, 井内勝哉, 西槙貴代美, 高見新也, 赤芝洋紀, 志鷹義嗣, 桂研一郎, 片山泰朗, 太田成男

    日本分子生物学会年会プログラム・要旨集(Web)   35th   2012

  • アルツハイマーモデルマウスに対する他家骨髄単核球投与の認知機能改善効果

    金丸拓也, 金丸拓也, 上村尚美, 井内勝哉, 西槇貴代美, 横田隆, 高見新也, 赤芝洋紀, 志鷹義嗣, 桂研一郎, 片山泰朗, 太田成男

    日本分子生物学会年会プログラム・要旨集(Web)   35th   2012

  • 脂肪細胞における転写因子KLF15の過剰発現はSCD1発現を抑制し、インスリン分泌を増加させる

    永礼 智基, 阪上 浩, 松本 道宏, 曹 永恒, 酒井 真志人, 稲垣 健二郎, 松木 泰, 渡辺 英二郎, 池田 和貴, 田口 良, 上村 尚美, 太田 成男, 平松 隆司, 春日 雅人

    肥満研究   17 ( Suppl. )   140 - 140   2011.9

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

▼display all

Research Projects

  • Analysis of the molecular mechanism of immune function decline accompanying diabetes

    Grant number:20K11541  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    researchmap

  • 水素分子の炎症制御機構解析-慢性炎症を基盤とした生活習慣病対策に向けて-

    2017.4 - 2020.3

    日本学術振興会  科研費・基盤研究(C) 

    上村 尚美

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 水素分子の糖尿病改善効果と遺伝子発現誘導における作用機序の解明

    2014.4 - 2017.3

    日本学術振興会  科研費・基盤研究(C) 

    上村 尚美

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Mechanism to exert multi-functions of molecular hydrogen for health-care and the prevention of diseases

    Grant number:26282198  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Ohta Shigeo, KAMIMURA Naomi, WOLF Alexander, IUCHI Katsuya, NISHIMAKI Kiyomi, ICHIMIYA Harumi

      More details

    Grant amount:\15600000 ( Direct Cost: \12000000 、 Indirect Cost:\3600000 )

    We previously reported that molecular hydrogen (H2) acts as a novel antioxidant to exhibit multiple functions. H2 regulates various signal transduction pathways and the expression of many genes for health-care and the prevention of life style related diseases. However, the primary targets of H2 in the signal transduction pathways are unknown. Here, we attempted to determine how H2 regulates gene expression.
    We found that H2 regulates gene expression via the Ca(2+) signal transduction pathway by modifying the free radical-dependent generation of oxidized phospholipid mediators. This mechanism explains the decrease in inflammatory cytokines. In addition, to suppress metabolic syndrome,H2 induces expression of the PGC-1α gene, followed by stimulation of the PPARα pathway that regulates FGF21, and the fatty acid and steroid metabolism. The expression of PGC-1α might be regulated indirectly through sequential regulation by H2, 4-hydroxy-2-nonenal, and Akt/FoxO1 signaling.

    researchmap

  • Protective effects of hydrogen against irradiation

    Grant number:24651055  2012.4 - 2014.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    OHTA Shigeo, KAMIMURA Naomi, WOLF Alexander, NISHIMAKI Kiyomi, ICHIMIYA Harumi, YOKOTA Takashi

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Ionizing irradiation produces free radicals such as hydroxyl radical (•OH) by reacting with water. Then, these free radicals act as a trigger for initiating the free radical chain reaction, resulting in the generation of lipid peroxides, which cause the damages in cells. The author has shown that molecular hydrogen (H2) reacts with •OH to protect cells. Moreover, H2 protects cells, organs and mice against irradiation. This study revealed that a low concentration (~0.08 mM) of molecular hydrogen (H2) terminates the free radical chain reaction to prevent lipid peroxides and to protect cells. The author would like to direct that this study is valuable as a basic investigation, but insufficient for the actual application in public.

    researchmap

  • 生体内酸化ストレスの定量的評価システムを用いた水素分子による糖尿病改善効果の解析

    2011.4 - 2014.3

    日本学術振興会  科研費・基盤研究(C) 

    上村 尚美

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Preventive effects of geriatric and life-style related diseases by oral administration of a novel hydrogen-producing material

    Grant number:23300257  2011.4 - 2014.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    OHTA Shigeo, KAMIMURA Naomi, WOLF Alexander, NISHIMAKI Kiyomi, ICHIMIYA Harumi, YOKOTA Takashi

      More details

    Grant amount:\17290000 ( Direct Cost: \13300000 、 Indirect Cost:\3990000 )

    MgH2 produces molecular hydrogen (H2) by reacting with water. Safety of MgH2 was confirmed by excess oral administration in long term in mice. Hydrogen was increased in the blood in rats after oral administration of MgH2. The oral administration of MgH2 effectively reduced blood triglyceride in 2-type diabetic model mice. To investigate the molecular mechanism, the change in gene expression between before and after its administration was comprehensively analyzed by using microarray. As the results, following the increase in PGC-1alpha expression increased expressions in genes involved in fatty acid and cholesterol metabolism. Thus, this study suggests the preventive effects of oral administration of MgH2 in lifestyle related diseases in model mice.

    researchmap

  • Evaluation of mechanisms by which caloric restriction regulates mitochondrial function

    Grant number:22590814  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    SHINMURA Ken, SUEMATSU Makoto, FUKUDA Keiichi, OTA Shigeo, TSUBOTA Kazuo, ADACHI Takeshi, SANO Motoaki, KAMIMURA Naomi

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    Caloric restriction (CR) confers cardioprotection against ischemia/reperfusion injury. We speculated that CR primes mitochondria for stress-resistance by post-transcriptional modification of specific mitochondrial proteins. We found that deacetylation of

    researchmap

  • 糖尿病の予防・改善における水素の効果

    2008.4 - 2011.3

    日本学術振興会  科研費・基盤研究(C) 

    上村 尚美

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Development toward preventive application of molecular hydrogen with a novel concept for lifestyle-related diseases

    Grant number:20300230  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    OHTA Shigeo, OHSAWA Ikuroh, KAMIMURA Naomi

      More details

    Grant amount:\19240000 ( Direct Cost: \14800000 、 Indirect Cost:\4440000 )

    Persistent oxidative stress is one of the major causes of most lifestyle-related diseases, cancer and the aging process. We have proposed that molecular hydrogen (H2) has potential as a "novel" antioxidant in preventive and therapeutic applications [Ohsawa et al., Nat Med. 2007 : 13 ; 688-94]. H2 has a number of advantages as a potential antioxidant : H2 rapidly diffuses into tissues and cells, and it is mild enough neither to disturb metabolic redox reactions nor to affect reactive oxygen species (ROS) that function in cell signaling, thereby, there should be little adverse effects of consuming H2. There are several methods to ingest or consume H2, including drinking H2-dissolved water (hydrogen water). In this study, we have shown that model mice for dementia, diabetes, and arteriosclerosis were improved by drinking hydrogen

    researchmap

  • 発がん時におけるミトコンドリア遺伝子体細胞変異の蓄積によるがん増殖促進機構

    Grant number:18012045  2006 - 2007

    日本学術振興会  科学研究費助成事業  特定領域研究

    太田 成男, 大澤 郁朗, 上村 尚美

      More details

    Grant amount:\10900000 ( Direct Cost: \10900000 )

    大部分のがん細胞のミトコンドリアDNA(mtDNA)には、体細胞変異が蓄積している。発がん初期段階でmtDNAに変異が生じると変異mtDNAと正常mtDNAが混在した状態から、細胞内で変異mtDNAだけの状態に移行し、ついで変異mtDNAだけをもつ細胞のみの集団に移行する.本研究の目的は、(1)発がんにおける過程におけるmtDNA体細胞変異の蓄積の分子機構を明らかにする。(2)発がん時における変異mtDNAが原因のアポトーシス抑制機構を明らかにする。(3)ミトコンドリア機能が低下するにもかかわらず、細胞増殖が促進される機構を明らかにする。
    患者のがん組織のミトコンドリアDNAの全塩基配列を決定し、がん細胞と正常細胞のミトコンドリアDNAの配列の違いを比較し、抗癌剤耐性との相関関係を調べ、正の相関関係があることを明らかにした。また、抗癌剤耐性の細胞株のミトコンドリアDNA塩基配列を決定し、そのミトコンドリアDNAを別細胞に移植し、抗癌剤耐性が消失することから抗癌剤耐性はミトコンドリアDNAに存在することを明確にした。
    さらに抗癌剤耐性細胞を作り出し、その60%にはミトコンドリアDNAの変異が生じており、ミトコンドリアを移植する方法によって抗癌剤耐性が消失することから、これもミトコンドリアに抗癌剤耐性の原因があることを明確にした。
    抗癌剤はアポトーシスを誘導するので、ミトコンドリアDNAの変異によってアポトーシスが阻害され、がん細胞にミトコンドリアDNAの変異が蓄積することを明確にした。さらに、ミトコンドリア機能が低下することと相関していることを明らかにした。乳酸が上昇しているので、ミトコンドリア機能を代償するために解糖系が亢進していることを明らかにした。

    researchmap

  • Research for requirement of down-regulation of energy metabolism for neuronal differentiation

    Grant number:17500263  2005 - 2007

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OHSAWA Ikuroh, KAMIMURA Naomi, OHTA Shigeo

      More details

    Grant amount:\3670000 ( Direct Cost: \3400000 、 Indirect Cost:\270000 )

    Only a few human neuroblastoma cell-lines maintain the potential for neuronal differentiation. We noticed by chance that differentiable human neuroblastomas including SH-SY5Y have a specific mutation in the dihydrolipoamide-succinyltransferase (DLST) gene, whose product is a component of the α-ketoglutarate-dehydrogenase complex involved in mitochondrial energy metabolism. Here we demonstrate a requirement of energy-reduction for neuronal differentiation by restoring SH-SY5Y with the wild-type DLSTgene. Up-regulation of DLST activity increased mitochondrial membrane potential and impaired neuronal differentiation. The impairment was partially rescued by treatment with inhibitors of energy metabolism. Additionally, down-regulation of DLST expression with small interfering RNA enhanced neuronal differentiation in rat pheochromocytoma PC12 and primary cultured neocortical cells. We further found that mitochondrial membrane potential among SH-SY5Y cells was heterogeneous and lower in neuroblastic type cells. It is thus concluded that the casual mutation conferred the potential for differentiation on the neuroblastomas, suggesting that such mutants had been preferentially selected as a model cell-line for neuronal differentiation. The energy-reduction seemed to contribute to the differentiation by preventing cell-death. These results provide a new insight into neuronal differentiation.

    researchmap

  • 発癌時におけるミトコンドリア遺伝子体細胞変異に蓄積による核遺伝子発現制御

    Grant number:17013079  2005

    日本学術振興会  科学研究費助成事業  特定領域研究

    太田 成男, 宮戸 靖幸, 大澤 郁朗, 上村 尚美

      More details

    Grant amount:\5400000 ( Direct Cost: \5400000 )

    (1)癌細胞におけるミトコンドリアDNAの体細胞変異の蓄積
    多くの癌組織、癌細胞のmtDNAに体細胞変異が蓄積していることが明らかにされている。しかし、この体細胞変異の蓄積が、癌の形成過程の二次的結果として生じているのか、癌形成の原因のひとつとして、癌の促進に関与したために変異mtDNAをもつ癌細胞が多くなったのか、明らかではなかった。
    (2)サイブリドを用いたmtDNAの役割の研究
    細胞には核ゲノムとミトコンドリアゲノムが共存しているので、mtDNAの役割を明らかにするためには、核が共通でmtDNAだけが異なる細胞を比較しなければならない。そこで、mtDNAを消失しているHeLa細胞と脱核した細胞質を融合し、核が共通で正常mtDNAをもつ細胞と変異mtDNAをもつ細胞を作製した。この融合細胞を細胞質の融合であるのでサイブリド(cybrid)と呼ぶ。このサイブリドを用いて、mtDNAの癌の増殖速度へ対する効果とアポトーシ耐性効果、抗癌剤への耐性効果を調べた。
    (3)癌の増殖に対する変異mtDNAの効果
    変異mtDNAを持つサイブリド細胞と正常mtDNAもつサイブリド細胞をヌードマウスに移植すると、移植直後からの腫瘍体積の増加が正常mtDNAをもつサイブリド細胞より速く、mtDNA変異が癌増殖促進に寄与していることが示された。変異mtDNAをもつサイブリドでは、自発的におきるアポトーシス頻度が低下しており、アポトーシスの頻度の低下が見かけ上の増殖促進に寄与していることが示唆された。
    (4)抗癌剤へ対する耐性獲得とmtDNA変異
    mtDNA変異によってアポトーシスが抑制されたので、抗癌剤への耐性へのmtDNAの役割をサイブリドを用いて解析した。変異mtDNAをもつサイブリドは正常mtDNAをもつサイブリドよりも抗癌剤耐性であった。

    researchmap

  • 核遺伝子産物MIDASによるミトコンドリア増殖機構の解明

    2004.4 - 2007.3

    日本学術振興会  科研費・若手研究(B) 

    上村 尚美

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Development of a novel therapy for brain infarction using a cell-penetrating protein exhibiting enhanced anti-cell death activity

    Grant number:16390257  2004 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    OHTA Shigeo, KATSURA Ken-ichiro, ASOH Sadamitsu, KAMINURA Naoomi

      More details

    Grant amount:\14400000 ( Direct Cost: \14400000 )

    Many practical therapies have been explored for clinical applications to ischemic cerebral infarction; however, the most are still insufficient for treatments for acute stroke. We show here a potential combination therapy in a rat focal ischemic model to improve neurological symptoms as well as reduce infarct volumes at the maximum level. We applied a protein transduction technology using the artificial anti-death FNK protein fused with a protein-transduction-domain peptide (PTD-FNK). When PTD-FNK was administrated at1hr after initiating ischemia followed by the administration of an immunosuppressant FK506 with a 30-min time lag, infarct volumes of the total brain and cortex were markedly reduced to a level of 27% and 14%, respectively. This procedure not only reduced the infarct volume and edema, but also markedly improved neurological symptoms. The therapeutic effect continued at least for 1 week after ischemia. FK506 inhibited the transduction of PTD-FNK in vitro, which explains the requirement of a time lag for the administration of FK506. An additional in vitro experiment showed that PTD-FNK, when administered 30 min before FK506, gave the maximal protective effect through reducing an intracellular calcium concentration. We propose that this combination therapy would give a synergistic protective effect of both drugs, reducing adverse effect of FK506.

    researchmap

▼display all